Dani Brasino, PhD

Assistant Professor

PRONOUNS she/her

Dani Brasino smiling
Pronouns she/her
Affiliated Department(s)
  • Dept of Microbiology and Molecular Genetics
  • UVM Cancer Center associate member

BIO

  • B.S. Nutrition Science at University of Texas
  • At UT, gained research experience in the lab of Stephen Hursting contributing to in vitro and in vivo studies of dietary impacts on breast and pancreatic cancer progression.
  • Doctoral research in the lab of Christopher Bowman at the University of Colorado. Thesis research focused on the development of manipulable synthetic phospholipids using photo-and click-chemistries. These lipids were integrated into membranes as part of a multi-university, artificial cell project.  
  • Starting in 2018, postdoctoral research began at the new Cancer Early Detection Advanced Research (CEDAR) Center within the Knight Cancer Institute at Oregon Health and Science University in Portland, Oregon.  Beyond contributions to multiple research projects as part of the center’s collaborative structure, her primary research centered around the development of a polycarbonate-based organ-on-chip platform to enable host-microbe interaction studies between the gut microbiome and distal disease.
  • Joined the Department of Microbiology and Molecular Genetics in August 2024.

Publications

Dani Brasino's publications

Area(s) of expertise

  • Organ-on-Chip Device Fabrication and Optimization
  • Host-Microbe Interaction Modeling
  • Gut Microbiome and Cancer Interactions

Bio

  • B.S. Nutrition Science at University of Texas
  • At UT, gained research experience in the lab of Stephen Hursting contributing to in vitro and in vivo studies of dietary impacts on breast and pancreatic cancer progression.
  • Doctoral research in the lab of Christopher Bowman at the University of Colorado. Thesis research focused on the development of manipulable synthetic phospholipids using photo-and click-chemistries. These lipids were integrated into membranes as part of a multi-university, artificial cell project.  
  • Starting in 2018, postdoctoral research began at the new Cancer Early Detection Advanced Research (CEDAR) Center within the Knight Cancer Institute at Oregon Health and Science University in Portland, Oregon.  Beyond contributions to multiple research projects as part of the center’s collaborative structure, her primary research centered around the development of a polycarbonate-based organ-on-chip platform to enable host-microbe interaction studies between the gut microbiome and distal disease.
  • Joined the Department of Microbiology and Molecular Genetics in August 2024.

Areas of Expertise

  • Organ-on-Chip Device Fabrication and Optimization
  • Host-Microbe Interaction Modeling
  • Gut Microbiome and Cancer Interactions

Lab Team

Ethan Putnam, Jake Spiegler, Alina Staten